0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¿µ¼ºÃøÁ¤µµ±¸°³¹ß ¹× Æò°¡

Development and Validation of the New Version of Spirituality Assessment Scale

Journal of Korean Academy of Nursing 2020³â 50±Ç 1È£ p.132 ~ 146
KMID : 0806120200500010132
°íÀϼ± ( Ko Il-Sun ) - ¿¬¼¼´ëÇб³ °£È£´ëÇÐ

ÃÖ¼Ò¿µ ( Choi So-Young ) - Pennsylvania State University College of Nursing
±èÁø¼÷ ( Kim Jin-Sook ) - ¿ì¼Û´ëÇб³ °£È£Çаú

Abstract

Purpose: The purpose of this study was to develop a new version of Spirituality Assessment Scale (N-SAS) and verify its reliability and validity.

Methods: The total of 59 preliminary items for the N-SAS were selected through a literature review, two rounds of experts¡¯ content validation, cognitive interviews, and pre-tests. Verification of its reliability and validity was divided into two phases. In Phase I, questionnaires were collected from 219 adults. Reliability was tested using Cronbach¡¯s alpha, validity with item analysis, and exploratory factor analysis. In Phase II, questionnaires developed based on the results of Phase I were collected from 225 adults. Reliability was tested using Cronbach¡¯s alpha, validity with confirmatory factor analysis, and criterion validity.

Results: The final version of the N-SAS comprised two dimensions (vertical and horizontal), four domains (relationship with God; meaning of life and self-integration; self-transcendence; and relationship with others, neighborhoods, and nature), and 44 items were identified. Total Cronbach¡¯s ¥á was .97; those of each subscale ranged from .79 to .98. N-SAS scores were positively correlated with the scores of Howden¡¯s Spiritual Assessment Scale (r=.81, p <.001).

Conclusion: Findings suggest that the N-SAS can be used to measure spirituality in adults. The use of N-SAS is expected to facilitate perceiving patient¡¯s spiritual needs and providing spiritual care.
KeyWords
¿µ¼º, ¿äÀκм®(Åë°è), ½Å·Úµµ¿Í Ÿ´çµµ
Spirituality, Factor Analysis, Statistical, Reliability and Validity
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed